Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma

Author:

Cloughesy Timothy F.1,Petrecca Kevin2,Walbert Tobias3,Butowski Nicholas4,Salacz Michael5,Perry James6,Damek Denise7,Bota Daniela8,Bettegowda Chetan9,Zhu Jay-Jiguang10,Iwamoto Fabio11,Placantonakis Dimitris12,Kim Lyndon1314,Elder Brad15,Kaptain George16,Cachia David17,Moshel Yaron18,Brem Steven19,Piccioni David20,Landolfi Joseph21,Chen Clark C.22,Gruber Harry2324,Rao Aliz R.2325,Hogan Daniel2326,Accomando William2327,Ostertag Derek2328,Montellano Tiffany T.2329,Kheoh Thian2330,Kabbinavar Fairooz2331,Vogelbaum Michael A.32

Affiliation:

1. University of California, Los Angeles, Los Angeles, California

2. Montreal Neurological Institute, Montreal, Quebec, Canada

3. Henry Ford Hospital, Detroit, Michigan

4. University of California, San Francisco, San Francisco, California

5. University of Kansas Medical Center, Kansas City, Kansas

6. Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, Canada

7. University of Colorado, Aurora, Colorado

8. University of California, Irvine, Irvine, California

9. Johns Hopkins University School of Medicine, Baltimore, Maryland

10. University of Texas Health Science Center, Houston, Texas

11. Columbia University, New York, New York

12. New York University Langone Medical Center, New York, New York

13. Thomas Jefferson University, Philadelphia, Pennsylvania

14. Mount Sinai Hospital, New York, New York

15. Ohio State University, Columbus, Ohio

16. John Theurer Cancer Center, Hackensack University, Hackensack, New Jersey

17. Medical University of South Carolina, Charleston, South Carolina

18. Overlook Medical Center, Summit, New Jersey

19. Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

20. University of California San Diego, San Diego, California

21. JFK Medical Center, Edison, New Jersey

22. University of Minnesota, Minneapolis, Minnesota

23. Formerly Tocagen Inc, San Diego, California

24. AmpiSwitch, San Diego, California

25. Bionano Genomics, San Diego, California,

26. Impossible Foods, San Francisco, California

27. Fate Therapeutics, San Diego, California

28. Abintus Bio, San Diego, California

29. Kura Oncology, San Diego, California

30. Mirati Therapeutics, San Diego, California

31. Puma Biotechnology, Los Angeles, California

32. Cleveland Clinic Foundation, Moffitt Cancer Center, Tampa, Florida

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference21 articles.

Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3